| Lacey Gunn, MD, PHD | |
|
2400 Eastpoint Pkwy Ste 550, Louisville, KY 40223-4154 | |
| (502) 253-6630 | |
| (502) 253-6639 |
| Full Name | Lacey Gunn |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 2400 Eastpoint Pkwy Ste 550, Louisville, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033529458 | NPI | - | NPPES |
| 7100383600 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 49865 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jewish Hospital & St Mary's Healthcare | Louisville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Louisville Physicians Inc | 3476725599 | 1102 |
News Archive
Nearly 60,000 people die from bleeding each year, and though injuries that result in extreme blood loss have long been a sight all too common in areas like West Philadelphia, the national spotlight has certainly shone upon the issue of late.
Scientific studies of a unique Australian frog could lead to the development of new ways to improve livestock production levels and boost the prospects of maintaining human muscle strength into old age.
Sanofi announced today new Phase II data showing that treatment with a novel, investigational, selective JAK2 inhibitor (SAR302503) reduced spleen size and improved constitutional symptoms in patients with intermediate-2 or high-risk primary or secondary myelofibrosis (MF), a hematologic malignancy with unmet medical needs.
GENFIT, a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announces the development of a new reliable and non-invasive diagnostic method, based on the measurement of a novel type of blood biomarker: small non-coding RNA, or miRNA.
Scientists have moved a step closer to correcting some unhealthy gene mutations with diet, according to a new research report appearing in the April 2012 issue of the journal GENETICS.
› Verified 4 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740586213 PECOS PAC ID: 5597867184 Enrollment ID: O20070228000503 |
News Archive
Nearly 60,000 people die from bleeding each year, and though injuries that result in extreme blood loss have long been a sight all too common in areas like West Philadelphia, the national spotlight has certainly shone upon the issue of late.
Scientific studies of a unique Australian frog could lead to the development of new ways to improve livestock production levels and boost the prospects of maintaining human muscle strength into old age.
Sanofi announced today new Phase II data showing that treatment with a novel, investigational, selective JAK2 inhibitor (SAR302503) reduced spleen size and improved constitutional symptoms in patients with intermediate-2 or high-risk primary or secondary myelofibrosis (MF), a hematologic malignancy with unmet medical needs.
GENFIT, a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announces the development of a new reliable and non-invasive diagnostic method, based on the measurement of a novel type of blood biomarker: small non-coding RNA, or miRNA.
Scientists have moved a step closer to correcting some unhealthy gene mutations with diet, according to a new research report appearing in the April 2012 issue of the journal GENETICS.
› Verified 4 days ago
| Entity Name | University Of Louisville Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366722316 PECOS PAC ID: 3476725599 Enrollment ID: O20111017000036 |
News Archive
Nearly 60,000 people die from bleeding each year, and though injuries that result in extreme blood loss have long been a sight all too common in areas like West Philadelphia, the national spotlight has certainly shone upon the issue of late.
Scientific studies of a unique Australian frog could lead to the development of new ways to improve livestock production levels and boost the prospects of maintaining human muscle strength into old age.
Sanofi announced today new Phase II data showing that treatment with a novel, investigational, selective JAK2 inhibitor (SAR302503) reduced spleen size and improved constitutional symptoms in patients with intermediate-2 or high-risk primary or secondary myelofibrosis (MF), a hematologic malignancy with unmet medical needs.
GENFIT, a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announces the development of a new reliable and non-invasive diagnostic method, based on the measurement of a novel type of blood biomarker: small non-coding RNA, or miRNA.
Scientists have moved a step closer to correcting some unhealthy gene mutations with diet, according to a new research report appearing in the April 2012 issue of the journal GENETICS.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lacey Gunn, MD, PHD Po Box 950248, Louisville, KY 40295-0248 Ph: (866) 273-5392 | Lacey Gunn, MD, PHD 2400 Eastpoint Pkwy Ste 550, Louisville, KY 40223-4154 Ph: (502) 253-6630 |
News Archive
Nearly 60,000 people die from bleeding each year, and though injuries that result in extreme blood loss have long been a sight all too common in areas like West Philadelphia, the national spotlight has certainly shone upon the issue of late.
Scientific studies of a unique Australian frog could lead to the development of new ways to improve livestock production levels and boost the prospects of maintaining human muscle strength into old age.
Sanofi announced today new Phase II data showing that treatment with a novel, investigational, selective JAK2 inhibitor (SAR302503) reduced spleen size and improved constitutional symptoms in patients with intermediate-2 or high-risk primary or secondary myelofibrosis (MF), a hematologic malignancy with unmet medical needs.
GENFIT, a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announces the development of a new reliable and non-invasive diagnostic method, based on the measurement of a novel type of blood biomarker: small non-coding RNA, or miRNA.
Scientists have moved a step closer to correcting some unhealthy gene mutations with diet, according to a new research report appearing in the April 2012 issue of the journal GENETICS.
› Verified 4 days ago
Jaivanti Lohano, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2215 Portland Ave, Louisville, KY 40212 Phone: 502-774-8631 Fax: 502-778-3499 | |
John L Markert, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1169 Eastern Pkwy Ste 2265, Louisville, KY 40217 Phone: 502-635-7455 Fax: 502-634-9296 | |
Dr. Jerry Randolph Smith, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3015 Wilson Ave, Park Duvalle Cnc, Louisville, KY 40211 Phone: 502-774-4401 Fax: 502-772-4783 | |
Dr. Jill Marie Jacobs, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8019 Dixie Hwy Ste 101, Louisville, KY 40258 Phone: 502-254-3898 | |
Chassidy Weatherford, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4950 Norton Healthcare Blvd, Louisville, KY 40241 Phone: 502-394-6350 | |
Michael James Gaffney, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3532 Ephraim Mcdowell Drive, Louisville, KY 40205 Phone: 502-456-6200 Fax: 502-456-6655 | |
Veronica Anne Kavorkian, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2701 Chamberlain Ln, Louisville, KY 40245 Phone: 502-243-9044 Fax: 502-243-8482 |